Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Clinical trial NCT03059446 · TERMINATED
Trial details
- NCT number
- NCT03059446
- Sponsor
- Tobira Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2021-01-05
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.